Otago Innovation operate as a resource for University of Otago Researchers to be able to transfer their technology to real-world projects. Currently, our portfolio is around about 10 active startups and they range from developing self-regulation skills for children to an anti-inflammatory plant molecule that improves the ability of the body to process blood sugar. Read on to discover some of our success stories.
The technology has been patented and the research team has worked with Otago Innovation and external stakeholders to bring a natural dahlia-extract supplement to the market, aiming to support normal blood sugar and insulin levels.
Learn More
Chitogel is a global medical device company offering a leading edge wound healing gel for use in endoscopic sinus surgery.
Learn More
Supporting researchers internationally, Professor Mark Hampton and the team at Mātai Hāora – the Centre for Redox Biology And Medicine at the University of Otago, Christchurch have produced the Protein Carbonyl Assay Kit. This ready-to-use assay provides researchers with a reliable and efficient method for assessing oxidative damage across numerous scientific applications.
Learn More
Developed by Prof. Dione Healey, clinical psychologist at the University of Otago, ENGAGE™ teaches young mokopuna self-regulation of their emotional, cognitive and behavioural skills. Following successful trials in Dunedin, Auckland and Bay of Plenty, ENGAGE™ is being rolled out across Early Childhood Centres in New Zealand thanks to Government funding.
Learn More
Founded by Dr Sarah Diermeier, an Otago-based biochemist, who has been working on developing a new class of therapeutics that target long non-coding RNA in cancer. The company was set up through Otago Innovation to commercialise its work. Investors have committed $14 million investment.
Learn MoreKeep Informed
Receive the latest information on funding, advice and connections direct to your inbox.